SPDYA Antikörper (AA 147-175)
-
- Target Alle SPDYA Antikörper anzeigen
- SPDYA (Speedy Homolog A (SPDYA))
-
Bindungsspezifität
- AA 147-175
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SPDYA Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)
- Homologie
- M, Rat
- Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
- Immunogen
- This SPDYA antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 147-175 amino acids from the Central region of human SPDYA.
- Klon
- RB24658
- Isotyp
- Ig Fraction
-
-
- Applikationshinweise
- WB: 1:1000. WB: 1:1000. IHC-P: 1:50~100. FC: 1:10~50
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Haltbarkeit
- 6 months
-
-
Temporal-spatial expressions of Spy1 in rat sciatic nerve after crush." in: Cellular and molecular neurobiology, Vol. 33, Issue 2, pp. 213-21, (2013) (PubMed).
: "
-
Temporal-spatial expressions of Spy1 in rat sciatic nerve after crush." in: Cellular and molecular neurobiology, Vol. 33, Issue 2, pp. 213-21, (2013) (PubMed).
-
- Target
- SPDYA (Speedy Homolog A (SPDYA))
- Andere Bezeichnung
- SPDYA (SPDYA Produkte)
- Hintergrund
- SPDYA (speedy homolog A (Drosophila)) regulates the G1/S phase transition of the cell cycle by binding and activating CDC2, CDK2 and CDKN1B/KIP1. SPDYA can activate CDK2 without promoting CDK2 phosphorylation. SPDYA mediates cell survival during the DNA damage process through activation of CDK2.
- Molekulargewicht
- 36463
- NCBI Accession
- NP_001008779, NP_001136106, NP_877433
- UniProt
- Q5MJ70
-